Protocol · Hematological/Genetic Disorders
Sickle Cell Disease Supportive Care Protocol
Folic Acid and Zinc are the core of this stack, with 5 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Sickle Cell Disease Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
7 supplements · 1 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Folic Acid | Amount listed: 1 mg daily | Essential for RBC production; high turnover in SCD increases folate requirements | Not graded yet | |
| Zinc | Amount listed: 25–50 mg daily | Often deficient in SCD; supports immune function and wound healing | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Alpha-Lipoic Acid | Amount listed: 300–600 mg daily | Antioxidant; may help reduce oxidative stress in sickle cell disease
| Grade C for Oxidative Stress Biomarkers4 studies · 60 people | |
| Vitamin D | Amount listed: 2,000–4,000 IU daily (titrate to levels) | Deficiency very common in SCD; may affect pain and bone health | Not graded yet | |
| L-Arginine | Amount listed: 0.1 g/kg three times daily | Supports nitric oxide production; may reduce pulmonary hypertension risk | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Anti-inflammatory; may reduce pain crisis frequency | Not graded yet | |
| Vitamin E | Amount listed: 400–800 IU daily | Antioxidant; protects RBC membranes from oxidative damage | Not graded yet | |
How this protocol works
In plain language
Sickle Cell Disease (SCD) is an inherited blood disorder where red blood cells become rigid and shaped like sickles. These abnormal cells can block blood flow, causing pain crises, organ damage, and other serious complications.
GENETIC CAUSE:
- Mutation in hemoglobin gene (HbS)
- Must inherit from both parents (autosomal recessive)
- Carriers (sickle cell trait) usually asymptomatic
COMMON COMPLICATIONS:
- Pain crises: Blocked blood flow causing severe pain
- Anemia: Sickle cells die early (10-20 days vs 120 days)
- Infections: Increased susceptibility (esp. pneumococcal)
- Stroke: Even in children
- Acute chest syndrome: Lung crisis (can be fatal)
- Organ damage: Kidneys, spleen, liver, eyes
CRITICAL: SCD requires comprehensive medical management. This protocol is SUPPORTIVE ONLY.
MEDICAL TREATMENTS:
- Hydroxyurea: Increases fetal hemoglobin; reduces crises
- Blood transfusions: For severe anemia, stroke prevention
- L-glutamine (Endari): FDA-approved to reduce pain crises
- Voxelotor (Oxbryta): Increases hemoglobin
- Crizanlizumab (Adakveo): Reduces pain crises
- Bone marrow/stem cell transplant: Only cure
- Gene therapy: Emerging treatment
PREVENTIVE CARE:
- Penicillin prophylaxis (children)
- Vaccinations (pneumococcal, meningococcal, flu)
- Folic acid supplementation
- Adequate hydration
- Avoid extreme temperatures, high altitude
Folic acid* is essential due to high RBC turnover.
Zinc and vitamin D* deficiencies are very common.
Antioxidants* may help reduce oxidative stress.
Expected timeline: SCD is lifelong. Supplements support overall health and may help reduce some complications.